| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.01B | 16.27B | 4.67B | 9.32B | 5.04B | 4.54B |
| Gross Profit | 2.77B | 5.18B | 4.74B | 9.32B | 5.04B | 4.54B |
| EBITDA | 872.00M | 2.89B | 2.23B | -57.00M | 0.00 | 0.00 |
| Net Income | 2.22B | 2.30B | 1.30B | 1.66B | 1.25B | 618.00M |
Balance Sheet | ||||||
| Total Assets | 377.47B | 367.88B | 271.92B | 271.89B | 272.35B | 254.91B |
| Cash, Cash Equivalents and Short-Term Investments | 35.27B | 29.48B | 25.16B | 25.95B | 30.82B | 17.70B |
| Total Debt | 65.68B | 54.24B | 54.89B | 61.17B | 72.07B | 64.36B |
| Total Liabilities | 358.92B | 347.39B | 254.23B | 256.32B | 257.99B | 242.14B |
| Stockholders Equity | 18.34B | 19.72B | 17.69B | 15.57B | 14.36B | 12.78B |
Cash Flow | ||||||
| Free Cash Flow | -27.95B | -8.31B | 7.08B | 1.80B | 1.07B | 937.00M |
| Operating Cash Flow | -27.84B | -7.91B | 7.17B | 2.14B | 1.35B | 1.28B |
| Investing Cash Flow | 10.32B | 10.77B | 792.00M | -4.21B | -4.96B | -7.95B |
| Financing Cash Flow | -7.79B | 1.44B | -9.31B | -2.79B | 16.72B | 9.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £1.39B | 6.98 | 15.28% | 11.03% | 8.78% | -38.83% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £54.35B | 10.47 | 8.08% | 3.41% | -22.85% | -21.12% | |
66 Neutral | £1.36B | 0.87 | 11.68% | ― | 24.32% | 122.52% | |
65 Neutral | £1.42B | 5.39 | 12.70% | 4.74% | -4.98% | 3.02% | |
59 Neutral | £138.39M | 5.59 | 6.10% | 5.68% | 1.68% | -46.69% | |
47 Neutral | £758.21M | 11.65 | 5.16% | ― | -29.12% | 964.19% |